(Q36680576)

15 August 2017

How does early detection by screening affect disease progression? Modeling estimated benefits in prostate cancer screening (English)

1 reference

prostate cancer screening

15 August 2017

1 reference

1 reference

Elisabeth M Wever

1

1 reference

15 August 2017

Gerrit Draisma

series ordinal

2

1 reference

15 August 2017

Eveline A M Heijnsdijk

series ordinal

3

1 reference

15 August 2017

Harry J de Koning

series ordinal

4

1 reference

15 August 2017

15 March 2011

1 reference

15 August 2017

Medical Decision Making

1 reference

15 August 2017

31

1 reference

15 August 2017

4

1 reference

15 August 2017

550-558

1 reference

Cancer screening in the United States, 2010: a review of current American Cancer Society guidelines and issues in cancer screening

15 August 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4789305

Effects of mammography screening under different screening schedules: model estimates of potential benefits and harms

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4789305

Effect of rising chemotherapy costs on the cost savings of colorectal cancer screening

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4789305

Prostate cancer diagnosis and treatment after the introduction of prostate-specific antigen screening: 1986-2005

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4789305

Screening and prostate-cancer mortality in a randomized European study

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4789305

Lead time and overdiagnosis in prostate-specific antigen screening: importance of methods and context

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4789305

At what costs will screening with CT colonography be competitive? A cost-effectiveness approach

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4789305

Evaluating test strategies for colorectal cancer screening: a decision analysis for the U.S. Preventive Services Task Force

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4789305

Radical prostatectomy versus watchful waiting in localized prostate cancer: the Scandinavian prostate cancer group-4 randomized trial

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4789305

Quantifying the role of PSA screening in the US prostate cancer mortality decline

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4789305

Bayesian inference for the lead time in periodic cancer screening

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4789305

A stochastic simulation model of U.S. breast cancer mortality trends from 1975 to 2000.

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4789305

Effect of screening and adjuvant therapy on mortality from breast cancer

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4789305

Progress in cancer screening over a decade: results of cancer screening from the 1987, 1992, and 1998 National Health Interview Surveys

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4789305

Estimating key parameters in periodic breast cancer screening-application to the Canadian National Breast Screening Study data.

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4789305

Cost-effectiveness of opportunistic versus organised mammography screening in Switzerland.

5 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4789305

Colorectal cancer screening: a comparison of 35 initiatives in 17 countries.

5 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4789305

The SPECTRUM population model of the impact of screening and treatment on U.S. breast cancer trends from 1975 to 2000: principles and practice of the model methods.

5 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4789305

Lead times and overdetection due to prostate-specific antigen screening: estimates from the European Randomized Study of Screening for Prostate Cancer.

5 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4789305

Benefits and costs of using HPV testing to screen for cervical cancer

5 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4789305

Cost-effectiveness of screening for colorectal cancer in the general population.

5 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4789305

Cost-Effectiveness of Cervical Cancer Screening: Comparison of Screening Policies

5 September 2018

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/21406620

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Gleason score, age and screening: Modeling dedifferentiation in prostate cancer

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/21406620

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Identifiers

DOI

10.1177/0272989X10396717

1 reference

15 August 2017

1 reference

15 August 2017

PubMed publication ID

21406620

1 reference